Skip to content

Clorox

US · CLX #1495 by market cap Listed 1970
82.21 -1.31 -1.57%
Live - 5344 symbols - heartbeat 423s ago · 2026-10-08 08:22
Pre-market 82.21 +0.01%
After-hours 82.43 +0.27%
Overnight 81.77 -0.54%
Market cap
9.94B
P/B
110.50
EPS
4.81
Reader sentiment Are you bullish or bearish on CLX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
87.15% -0.06pp
Institutions
1,226 -7
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund69.38%
Hedge Fund6.08%
Public Company5.70%
Private Company2.91%
Government Pension Fund1.40%
Sovereign Wealth Fund0.90%
Family Office/Trust0.47%
Individual/Insider0.25%
Insurance Company0.11%
Other12.80%

Top holders as of 2026-06-30

BlackRock 8.31% · 10.04M sh
Vanguard Capital Management, LLC 7.09% · 8.58M sh
State Street Global Advisors 6.97% · 8.43M sh
Vanguard Portfolio Management, LLC 4.80% · 5.80M sh
Geode Capital Management, LLC 2.70% · 3.27M sh
UBS Asset Management 2.64% · 3.19M sh
Invesco Capital Management LLC 2.63% · 3.18M sh
Van Eck Associates Corporation 2.46% · 2.97M sh
Millennium Management LLC 2.39% · 2.89M sh
Invesco Ltd. 2.34% · 2.83M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 38 buys · 12 sells

NameRoleStake
Kevin Jacobsen Chief Financial Officer 0.09%
Eric Reynolds Chief Operating Officer 0.06%
Linda Rendle Chief Executive Officer 0.03%
Kirsten Marriner Executive VP and Chief People & Corporate Affairs Officer 0.02%
Pierre Breber Independent Director 0.01%
Angela Hilt Chief Legal Officer 0.01%
Chris Hyder Group President of Health & Hygiene 0.01%
Luc Bellet Treasurer 0.01%
Stacey Grier Executive VP and Chief Growth & Strategy Officer 0.01%
Nina Barton Executive VP and Group President of Care & Connection 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Christopher Williams Independent Director Other Derivative Acquisition +615 --
2026-09-29 Matthew John Shattock Independent Chairperson Other Derivative Acquisition +903 --
2026-09-29 Russell Weiner Independent Director Other Derivative Acquisition +643 --
2026-09-29 Pierre Breber Independent Director Other Derivative Acquisition +459 --
2026-09-29 Stephanie Plaines Independent Director Other Derivative Acquisition +438 --
2026-09-22 Angela Hilt Chief Legal Officer Other Acquisition +11,436 $83.94
2026-09-22 Kirsten Marriner Executive VP and Chief People & Corporate Affairs Officer Other Acquisition +12,389 $83.94
2026-09-22 Chris Hyder Group President of Health & Hygiene Other Acquisition +13,342 $83.94
2026-09-22 Nina Barton Executive VP and Group President of Care & Connection Other Acquisition +10,721 $83.94
2026-09-22 Linda Rendle Chief Executive Officer Other Acquisition +50,988 $83.94
2026-09-22 Laura Peck VP, Chief Accounting Officer & Corporate Controller Other Acquisition +2,192 $83.94
2026-09-22 Luc Bellet Treasurer Other Acquisition +11,913 $83.94
2026-07-21 Nina Barton Executive VP and Group President of Care & Connection Sale to Issuer -1,681 $95.69
2026-07-14 Chris Hyder Group President of Health & Hygiene Sale to Issuer -277 $94.75
2026-06-29 Christopher Williams Independent Director Other Derivative Acquisition +585 --
2026-06-29 Matthew John Shattock Independent Chairperson Other Derivative Acquisition +820 --
2026-06-29 Russell Weiner Independent Director Other Derivative Acquisition +595 --
2026-06-29 Pierre Breber Independent Director Other Derivative Acquisition +395 --
2026-06-29 Stephanie Plaines Independent Director Other Derivative Acquisition +392 --
2026-06-16 Angela Hilt Chief Legal Officer Other Acquisition +26,324 $94.97

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:22:19 · For reference only, not investment advice and not tailored to your situation.